IGC Pharma
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell IGC Pharma and other ETFs, options, and stocks.About IGC
IGC Pharma, Inc. is a clinical-stage pharmaceutical company that is focused on Alzheimer's disease, developing innovative solutions to address this devastating illness. It has two investigational drug assets targeting Alzheimer's disease: IGC-AD1, which is in a Phase 2 clinical trial as a treatment for agitation in dementia due to Alzheimer's and TGR-63 that is in pre-clinical development.
CEORam Mukunda
CEORam Mukunda
Employees70
Employees70
HeadquartersPotomac, Maryland
HeadquartersPotomac, Maryland
Founded2005
Founded2005
Employees70
Employees70
IGC Key Statistics
Market cap24.41M
Market cap24.41M
Price-Earnings ratio-3.27
Price-Earnings ratio-3.27
Dividend yield—
Dividend yield—
Average volume236.51K
Average volume236.51K
High today$0.32
High today$0.32
Low today$0.2986
Low today$0.2986
Open price$0.311
Open price$0.311
Volume515.42K
Volume515.42K
52 Week high$0.498
52 Week high$0.498
52 Week low$0.2525
52 Week low$0.2525
IGC News
TipRanks 6h
IGC Pharma Reports Transformative Year in Alzheimer’s InnovationIndia Globalization Capital ( (IGC) ) has released its Q4 earnings. Here is a breakdown of the information India Globalization Capital presented to its investor...
People also own
Based on the portfolios of people who own IGC. This list is generated using Robinhood data, and it’s not a recommendation.